Healthy Earnings Growth Sustains Pricey Biotech ETFs

Shaking off a spring swoon in growth stocks, the biotechnology sector exchange traded fund has surged back and reached a new high. Despite some concerns over pricier valuations, earnings growth continues to support the sector. The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB) fell over 20% in...